... New York Mellon Corp acquired a new stake in Albireo Pharma during the fourth quarter worth approximately $216,000. Ardsley Advisory Partners acquired a new stake in shares of Albireo Pharma in the fourth quarter valued at approximately $289,000. ...
https://sportsperspectives.com/2018/03/30/albireo-pharma-albo-rating-lowered-to-hold-at-bidaskclub.html
No comments:
Post a Comment